Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Endocrinology · Vitamin D-Dependent Rickets

Hormone Replacement and Treatment Goals

At a Glance

Vitamin D-dependent rickets requires treatment tailored to the subtype: active or bypassed vitamin D forms plus carefully measured calcium may replace the missing pathway. Frequent blood, urine, and kidney ultrasound checks help balance treatment and detect complications.

Treating Vitamin D-Dependent Rickets (VDDR) is not about “taking vitamins” in the traditional sense. It is a form of hormone replacement therapy. Because your child’s body cannot produce or use the active hormone on its own, doctors must provide the exact missing piece of the biological pathway [1][2].

Standard over-the-counter Vitamin D (cholecalciferol) usually fails for the most common subtypes (like 1A and 2A) because it requires the very “workstations” in the body that are defective to work correctly [1][3].

Subtype-Specific Treatments

Your child’s treatment plan is built specifically for their genetic defect. Never start, stop, substitute products, or alter doses without your specialist’s explicit instructions.

VDDR1A: Bypassing the Kidney

Since the kidneys cannot fully activate the Vitamin D signal, the treatment is to bypass this step.

  • Active Hormone Replacement: Doctors usually prescribe calcitriol (which is already fully active) or alfacalcidol (a prodrug that is activated in the liver, bypassing the kidney) [2][4].
  • Calcium Support: Because the goal is to harden the bones, children also take precise doses of elemental calcium (the actual amount of calcium in the supplement, not the total pill weight) [5]. Doses are carefully adjusted based on the child’s weight and regular blood tests [5].

VDDR1B: Bypassing the Liver

In this rare form, the liver cannot start the activation process.

  • Calcifediol or High-Dose Cholecalciferol: Calcifediol (25-hydroxyvitamin D) directly bypasses the liver defect but still relies on the kidney to finish the activation. In some cases with an intact kidney pathway, specialized high-dose cholecalciferol may also be an effective treatment [6][7].

VDDR2A (HVDRR): Overcoming Resistance

This is the most challenging form to treat because the body resists Vitamin D signals.

  • High-Dose Therapy: Treatment often requires very high, specialist-directed doses of oral calcium and active Vitamin D to try to push past the cellular resistance [8][9].
  • IV Calcium Infusions: If oral doses cannot safely correct severe, refractory hypocalcemia (dangerously low blood calcium), a hospital admission for intravenous (IV) calcium may be required. In rare, severe cases, a long-term central line (like a PICC or port) may be placed for intermittent infusions. This is a high-risk specialist option that carries significant risks of infection and blood clots [10][11].
  • Cinacalcet: In difficult cases where the Parathyroid Hormone (PTH) remains dangerously high despite calcium treatment, doctors may consider adding cinacalcet. This is an off-label adjunct drug with limited evidence that “tricks” the parathyroid glands into slowing down. However, it carries a real risk of worsening hypocalcemia and is not a routine next step [12][13].

Monitoring and Safety

Because the doses used in VDDR are highly specialized, treatment requires a delicate balancing act.

  • Blood and Urine Tests: Your child will need frequent labs to check calcium, phosphate, and PTH levels. Doctors also check urine to make sure the kidneys aren’t being overwhelmed with excreted calcium [14][15].
  • Kidney Protection: A major risk of high-dose treatment is nephrocalcinosis (calcium deposits in the kidneys). Even if blood tests look perfect, calcium can still build up in the kidneys [14][16]. Regular renal ultrasounds are essential [4][17].
  • Consistency is Key: Missing even a few doses can cause calcium levels to drop, leading to emergencies [4][9]. If your child develops symptoms like extreme thirst, frequent urination, nausea, or severe lethargy, contact your specialist immediately, as these can be signs of hypercalcemia (too much calcium) or urinary calcium excess [14].

Common questions in this guide

Why does ordinary vitamin D usually not treat vitamin D-dependent rickets?
In many forms of VDDR, the body cannot convert ordinary vitamin D into the active hormone or cannot respond to that hormone. Treatment therefore uses a form of vitamin D or calcium chosen to bypass the child’s specific defect.
What treatment is usually used for VDDR1A?
VDDR1A is usually treated with calcitriol or alfacalcidol, which bypass the kidney step needed to activate vitamin D. Children also receive carefully measured elemental calcium, meaning the actual amount of calcium in the supplement, with doses adjusted using body weight and blood tests.
How is difficult VDDR2A treated when calcium stays dangerously low?
VDDR2A often requires very high, specialist-directed doses of active vitamin D and oral calcium. If these cannot safely correct severe low blood calcium, hospital intravenous calcium may be needed; rare cases may require a long-term central line, which carries infection and blood-clot risks.
How does the care team monitor treatment and protect the kidneys?
Doctors check blood calcium, phosphate, and parathyroid hormone, along with calcium in the urine. Regular kidney ultrasounds look for nephrocalcinosis, or calcium deposits in the kidneys, even when blood tests are normal.
What symptoms should prompt a call to the specialist?
Extreme thirst, frequent urination, nausea, or severe tiredness can signal too much calcium or excess calcium in the urine. Contact your child’s specialist immediately if these symptoms develop.
Could cinacalcet help if parathyroid hormone remains high?
Cinacalcet may be considered in difficult VDDR2A cases when parathyroid hormone stays dangerously high despite calcium treatment. It is an off-label add-on with limited evidence and can worsen low blood calcium, so it is not a routine treatment.

Get notified when new evidence is published on Hypocalcemic vitamin D-resistant rickets.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Hereditary disorders of vitamin-D metabolism and its receptor.

    Lainis V, Katsouli O, Gazi S, et al.

    Hormones (Athens, Greece) 2025; (24(2)):335-346 doi:10.1007/s42000-025-00630-w.

    PMID: 39893280
  2. 2

    Genetic disorders of Vitamin D biosynthesis and degradation.

    Miller WL

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):101-108 doi:10.1016/j.jsbmb.2016.04.001.

    PMID: 27060335
  3. 3

    Clinical spectrum and diagnostic challenges of vitamin D dependent rickets type 1A (VDDR1A) caused by CYP27B1 mutation in resource limited countries.

    Aftab S, Khan SA, Malik MI, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):152-157 doi:10.1515/jpem-2022-0550.

    PMID: 36524979
  4. 4

    Genotype-phenotype Description of Vitamin D-dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease.

    Méaux MN, Harambat J, Rothenbuhler A, et al.

    The Journal of clinical endocrinology and metabolism 2023; (108(4)):812-826 doi:10.1210/clinem/dgac639.

    PMID: 36321535
  5. 5

    The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A.

    Ozden A, Doneray H

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(6)):781-789 doi:10.1515/jpem-2020-0691.

    PMID: 33823104
  6. 6

    Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?

    Molin A, Wiedemann A, Demers N, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2017; (32(9)):1893-1899 doi:10.1002/jbmr.3181.

    PMID: 28548312
  7. 7

    Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency.

    Jodar E, Campusano C, de Jongh RT, Holick MF

    European journal of nutrition 2023; (62(4)):1579-1597 doi:10.1007/s00394-023-03103-1.

    PMID: 36862209
  8. 8

    Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route.

    Abalı S, Tamura M, Turan S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(4)):557-562.

    PMID: 32049653
  9. 9

    Persistent Hyperparathyroidism in Vitamin D-Dependent Rickets Type 2A Does Not Prevent Normalization of Hypophosphatemia or Healing of the Rickets.

    Lodefalk M, Nilsson O

    Hormone research in paediatrics 2026; (99(6)):824-833 doi:10.1159/000546444.

    PMID: 40383122
  10. 10

    Experience of intravenous calcium treatment and long-term responses to treatment in a patient with hereditary vitamin D-resistant rickets resulting from a novel mutation.

    Bayramoğlu E, Şavaş Erdeve Ş, Shi Y, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(6)):647-651 doi:10.1515/jpem-2018-0399.

    PMID: 31141481
  11. 11

    Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia.

    Ersoy B, Kiremitci S, Isojima T, Kitanaka S

    Hormone research in paediatrics 2015; (83(1)):67-72 doi:10.1159/000367711.

    PMID: 25573344
  12. 12

    The Effectiveness of Cinacalcet as an Adjunctive Therapy for Hereditary 1,25 Dihydroxyvitamin D3-Resistant Rickets.

    Akıncı A, Dündar İ, Kıvılcım M

    Journal of clinical research in pediatric endocrinology 2017; (9(2)):172-178 doi:10.4274/jcrpe.3486.

    PMID: 27796266
  13. 13

    Cinacalcet treatment experience in hereditary vitamin D resistant rickets.

    Lucas J, Badia JL, Lucas E, Remon A

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(2)):313-318.

    PMID: 31926093
  14. 14

    Clinical and genetic analysis of two Chinese families with vitamin D-dependent rickets type IA and follow-up.

    Li Y, Yuan X, Chen R, et al.

    Orphanet journal of rare diseases 2020; (15(1)):273 doi:10.1186/s13023-020-01558-7.

    PMID: 33004071
  15. 15

    Clinical characteristics and long-term outcomes of 12 children with vitamin D-dependent rickets type 1A: A retrospective study.

    Lin Y, Guan Z, Mei H, et al.

    Frontiers in pediatrics 2022; (10()):1007219 doi:10.3389/fped.2022.1007219.

    PMID: 36405822
  16. 16

    Lifelong deformities in an adult caused by vitamin D‑dependent rickets type 1A: A case report.

    Yi C, Xu J, He J, et al.

    Experimental and therapeutic medicine 2022; (24(6)):762 doi:10.3892/etm.2022.11698.

    PMID: 36561972
  17. 17

    A Case of Vitamin D-Dependent Rickets Type 1A with a Novel Mutation in the Uzbek Population.

    Özcabı B, Tahmiscioğlu Bucak F, Jaferova S, et al.

    Journal of clinical research in pediatric endocrinology 2016; (8(4)):484-489 doi:10.4274/jcrpe.3128.

    PMID: 27353739

This page is for informational purposes only and does not constitute medical advice. A pediatric endocrinologist or other specialist should guide your child’s hormone replacement, calcium dosing, and monitoring.